Literature DB >> 1695534

Effects of aerosolised substance P on lung resistance in guinea-pigs: a comparison between inhibition of neutral endopeptidase and angiotensin-converting enzyme.

J O Lötvall1, B E Skoogh, P J Barnes, K F Chung.   

Abstract

1. We have examined in guinea-pigs, in vivo, the effects of inhibition of neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE) on the airway response to aerosolised substance P (SP). We aerosolised captopril (4.6 mM, 60 breaths; 210 nmol) to inhibit ACE and acetorphan (0.3, 1 and 3 mM, 60 breaths; 9 nmol, 33 nmol and 110 nmol respectively) to inhibit NEP. We also examined the effect of the highest dose of acetorphan (110 nmol) on the response to aerosolised acetylcholine (ACh). 2. Responsiveness to SP (or ACh) was measured as the change in lung resistance (RL) induced by nebulisation of increasing concentrations of SP (or ACh) before and after treatment with the inhibitor. PC200, defined as the provocative concentration inducing an increase in RL of 200% above baseline was calculated for each challenge. 3. Administration of acetorphan before the second SP-challenge induced a dose-dependent decrease in PC200 for SP amounting to 1.8 (+/- 0.3) log units after treatment with 11 nmol acetorphan. Treatment with vehicle before the second SP-challenge or with 3 mM acetorphan before the second ACh-challenge had no significant effect on PC200. 4. Treatment with captopril (21 nmol) induced only a small, nonsignificant leftward shift of PC200 to SP (0.3 +/- 0.2 log units). 5. We conclude that a NEP-like enzyme, but not ACE, regulates the response to aerosolised SP. We suggest that the same is true for SP released endogenously from sensory nerve endings in the airway epithelial layer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695534      PMCID: PMC1917469          DOI: 10.1111/j.1476-5381.1990.tb12053.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  THE EFFECTS OF ANAESTHESIA INDUCED BY URETHANE OR PHENOBARBITONE UPON THE DISTRIBUTION OF PERIPHERAL CATECHOL AMINES IN THE RAT.

Authors:  T L SPRIGGS
Journal:  Br J Pharmacol Chemother       Date:  1965-06

2.  Substance P-induced bronchoconstriction in the guinea pig. Enhancement by inhibitors of neutral metalloendopeptidase and angiotensin-converting enzyme.

Authors:  S A Shore; N P Stimler-Gerard; S R Coats; J M Drazen
Journal:  Am Rev Respir Dis       Date:  1988-02

3.  Enkephalinase inhibitor potentiates mammalian tachykinin-induced contraction in ferret trachea.

Authors:  K Sekizawa; J Tamaoki; P D Graf; C B Basbaum; D B Borson; J A Nadel
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030

4.  Stimulation of lung irritant receptors by cigarette smoke, carbon dust, and histamine aerosol.

Authors:  H Sellick; J G Widdicombe
Journal:  J Appl Physiol       Date:  1971-07       Impact factor: 3.531

5.  Influenza infection causes airway hyperresponsiveness by decreasing enkephalinase.

Authors:  D B Jacoby; J Tamaoki; D B Borson; J A Nadel
Journal:  J Appl Physiol (1985)       Date:  1988-06

6.  In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.

Authors:  M G Spillantini; P Geppetti; M Fanciullacci; S Michelacci; J M Lecomte; F Sicuteri
Journal:  Eur J Pharmacol       Date:  1986-06-05       Impact factor: 4.432

7.  Respiratory tract infections increase susceptibility to neurogenic inflammation in the rat trachea.

Authors:  D M McDonald
Journal:  Am Rev Respir Dis       Date:  1988-06

8.  Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.

Authors:  J M Lecomte; J Costentin; A Vlaiculescu; P Chaillet; H Marcais-Collado; C Llorens-Cortes; M Leboyer; J C Schwartz
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

9.  Neutral metalloendopeptidase in human lung tissue and cultured cells.

Authors:  A R Johnson; J Ashton; W W Schulz; E G Erdös
Journal:  Am Rev Respir Dis       Date:  1985-09

10.  Enkephalinase inhibitors potentiate substance P-induced secretion of 35SO4-macromolecules from ferret trachea.

Authors:  D B Borson; R Corrales; S Varsano; M Gold; N Viro; G Caughey; J Ramachandran; J A Nadel
Journal:  Exp Lung Res       Date:  1987       Impact factor: 2.459

View more
  6 in total

1.  Effect of neutral endopeptidase inhibitor on airway function and bronchial responsiveness in asthmatic subjects.

Authors:  G M Nichol; B J O'Connor; J M Lecomte; K F Chung; P J Barnes
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Differential effects of phosphoramidon on neurokinin A- and substance P-induced airflow obstruction and airway microvascular leakage in guinea-pig.

Authors:  J O Lötvall; W Elwood; K Tokuyama; P J Barnes; K F Chung
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

3.  Functional effects of phosphoramidon and captopril on exogenous neuropeptides in human nasal mucosa.

Authors:  C Châtelain; N Pochon; J S Lacroix
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

4.  The effect of peptidase inhibitors on bradykinin-induced bronchoconstriction in guinea-pigs in vivo.

Authors:  M Ichinose; P J Barnes
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

5.  Effects of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea pig lungs.

Authors:  C M Lilly; L Kobzik; A E Hall; J M Drazen
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

6.  A comprehensive review of the pharmacodynamics, pharmacokinetics, and clinical effects of the neutral endopeptidase inhibitor racecadotril.

Authors:  Marion Eberlin; Tobias Mück; Martin C Michel
Journal:  Front Pharmacol       Date:  2012-05-30       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.